A Registry for Patients Taking Uptravi (SPHERE)

Investigator: Zeenat Safdar, MD

Study Coordinator: Taniqua Warren

Status: Enrolling

ClinicalTrials.gov Number: N/A

Phone: 713.363.9280

Protocol Number: Pro00015141

Description

This is a US multi-center, prospective, real world, observational drug registry enrolling patients actively treated with Uptravi. Participating patients will be followed prospectively for a maximum of 18 months from the date of enrollment into the registry.
More to Explore